Journal Information
Vol. 39. Issue 6.
Pages 315-316 (June - July 2024)
Vol. 39. Issue 6.
Pages 315-316 (June - July 2024)
Editorial
Aprobación de biosimilares de ustekinumab: ¿un cambio en la primera línea del tratamiento biológico de la psoriasis?
Approval of ustekinumab biosimilars: First-line biological treatment for psoriasis set to change?
Visits
682
This item has received
Article information
These are the options to access the full texts of the publication Piel. Formación continuada en dermatología
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail